UW Health investigating vaccine response in those with IBS
![](/images/cbslogo_gray.png?x)
-
1:48
Man charged in Prince McCree’s murder sentenced to life in...
-
1:43
Onlookers enjoy Air and Water Show practice ahead of big weekend...
-
1:26
Brewers help fight hunger at Summer Sizzle event
-
2:07
’Justice, fairness, equity’: Milwaukee County leaders celebrate...
-
2:58
CBS 58 checks out Milwaukee’s 42nd annual German Fest
-
5:21
CBS 58’s Feel Good Fridays: Lakefront fun, German Fest and...
-
2:40
Meet CBS 58’s Pet of the Week: Esther
-
2:02
Pleasant start to a busy weekend in Milwaukee
-
2:10
Armed robbery attempt ends with gunfire exchange in Wauwatosa,...
-
3:08
Drew Burgoyne tastes treats in Tosa
-
3:06
Eduardo Galvan appointed MPS interim superintendent, despite...
-
2:13
Multiple festivals expected to draw thousands to Milwaukee’s...
MADISON, Wis. (CBS 58) -- The message has been clear from the beginning: if you're able to get the COVID-19 vaccine, you should.
That is especially true for people with compromised immune systems. However, the vaccine may not offer them the same level of protection, it depends on their condition.
UW Health has been investigating the effectiveness of the vaccine in people with Inflammatory Bowel Disease, better known as IBS. Patients usually have to take drugs that suppress the immune system. However, this study showed some promising results.
"Unlike other immunocompromised people, so like transplant recipients where they did similar studies, only half of their patients mounted antibodies," UW Health Gastroenterologist Dr. Freddy Caldera said. "97% of our patients did, which is similar to what they did with the general populations. 95% to 100% of people mounted an antibody response."
Dr. Caldera added that everyone is different and that it may be less effective for those with other diseases, but hopes this research helps reassure people.